← Leaderboards
Barbara Best North
Yaso Therapeutics Inc
$1,565,832
Attributed
$6,497,313
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2013–25$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,497,313 · 3
By mechanism
R44$6,497,313 · 3
Top collaborators
- Mary B Weitzel7 shared
- Donald P Waller4 shared
- Ann E. Jerse3 shared
- Betsy C. Herold2 shared
- Michael J Oldham2 shared
- William F Rencher2 shared
- Catherine Chappell1 shared
- Beatrice A. Chen1 shared
Most similar at Yaso Therapeutics Inc
Same institution · by research overlap
- Mary B Weitzel$1,959,557
- William F Rencher$500,000
- Michael J Oldham$644,063
- Aleksej Krunic$95,204
- Beatrice A. Chen$77,995
Others in their field
Top investigators on “Safety”
- David Heimbrook · Leidos Biomedical Research, Inc.$398,099,186
- Lawrence Corey · Fred Hutchinson Cancer Center$396,952,463
- Mitchell J Malone · Texas A&M Research Foundation$329,191,208
- Gary D Acton · University Of California-Davis$320,373,312
- Melynda Holmes · Technical Resources Inc$232,659,786
- Beth Baseler · Leidos Biomedical Research, Inc.$225,257,316
Research focus
SafetyPhase I Clinical TrialsAnalytical MethodVaginaSmall Business Innovation Research GrantGrantContraceptive AgentsClinical TrialsPharmaceutical PreparationsSimplexvirusFutureIn VitroContraceptive EfficacyServicesProductionFormulationRattusCyclic GmpMedicalDoseFeedbackFundingNeisseria GonorrhoeaeProduct Development
Grant awards (7)
First in Human Clinical Trial of a Contraceptive MPT YASO GEL$545,966
R44 · FY2025 · HD
Continuing Preclinical Development of PPCM Vaginal Contraceptive MPT to IND$984,778
R44 · FY2020 · HD
Continuing Preclinical Development of PPCM Vaginal Contraceptive MPT to IND$999,102
R44 · FY2019 · HD
Preclinical development of PPCM vaginal contraceptive to submit IND.$982,217
R44 · FY2018 · HD
Preclinical development of PPCM vaginal contraceptive to submit IND.$985,250
R44 · FY2017 · HD
Continuing Development of PPCM Vaginal Contraceptive Microbicide$1,000,000
R44 · FY2014 · AI
Continuing Development of PPCM Vaginal Contraceptive Microbicide$1,000,000
R44 · FY2013 · AI